Silvercrest Asset Management’s Zymeworks ZYME Stock Holding History

Silvercrest Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.85M	Buy	223,766 +60,117	+37%	+$1.53M	0.04%	432
2026 Q1	$4.1M	Sell	163,649 -18,141	-10%	-$429K	0.03%	451
2025 Q4	$4.79M	Sell	181,790 -91,007	-33%	-$1.99M	0.03%	438
2025 Q3	$4.66M	Sell	272,797 -7,929	-3%	-$113K	0.03%	435
2025 Q2	$3.52M	Hold	280,726	–	–	0.02%	473
2025 Q1	$3.34M	Sell	280,726 -1,619	-0.6%	-$22.1K	0.02%	467
2024 Q4	$4.13M	Sell	282,345 -2,770	-1%	-$38.7K	0.03%	448
2024 Q3	$3.58M	Sell	285,115 -113,029	-28%	-$1.23M	0.02%	421
2024 Q2	$3.39M	Buy	398,144 +5,123	+1%	+$45.6K	0.02%	449
2024 Q1	$4.13M	Buy	393,021 +17,173	+5%	+$191K	0.03%	421
2023 Q4	$3.91M	Hold	375,848	–	–	0.03%	413
2023 Q3	$2.38M	Sell	375,848 -950	-0.3%	-$7.02K	0.02%	461
2023 Q2	$3.26M	Buy	+376,798	New	+$3.37M	0.02%	428
2022 Q2	–	Sell	-222,627	Closed	-$1.46M	–	861
2022 Q1	$1.46M	Buy	222,627 +2,092	+0.9%	+$18.6K	0.01%	545
2021 Q4	$3.62M	Buy	220,535 +114,709	+108%	+$2.39M	0.02%	418
2021 Q3	$3.07M	Sell	105,826 -2,427	-2%	-$80.7K	0.02%	443
2021 Q2	$3.75M	Sell	108,253 -316	-0.3%	-$10K	0.02%	428
2021 Q1	$3.43M	Buy	108,569 +26,651	+33%	+$1.08M	0.02%	429
2020 Q4	$3.87M	Buy	+81,918	New	+$3.8M	0.03%	394

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Silvercrest Asset Management's ZYME Position: Q2 2026 in Review

Silvercrest Asset Management increased its Zymeworks (ZYME) stake by 37% in Q2 2026, buying an estimated $1.53M and bringing the position to 223,766 shares worth $5.85M. The position accounts for 0.04% of the portfolio, ranked #432.

Silvercrest Asset Management first reported a position in ZYME in Q4 2020 and has held it in 19 quarters since. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

Silvercrest Asset Management held 223,766 shares of Zymeworks worth $5.85M as of Q2 2026.
Silvercrest Asset Management bought 60,117 Zymeworks shares in Q2 2026, an estimated $1.53M.
Zymeworks made up 0.04% of Silvercrest Asset Management's portfolio in Q2 2026, its #432 holding.
Silvercrest Asset Management first reported a position in Zymeworks in Q4 2020 and has held it in 19 quarters since.
203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.